These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6290059)

  • 21. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
    Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
    Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Bakowski MT; Crouch JC
    Cancer Treat Rev; 1983 Sep; 10(3):159-72. PubMed ID: 6311415
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
    Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
    [No Abstract]   [Full Text] [Related]  

  • 24. Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
    Klastersky J; Nicaise C; Longeval E; Stryckmans P
    Cancer; 1982 Aug; 50(4):652-8. PubMed ID: 6284335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination cis-platinum and etoposide in small-cell lung cancer.
    Natale RB; Wittes RE
    Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 29. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Donnelly EJ; Raub WA
    Am J Clin Oncol; 1994 Dec; 17(6):527-37. PubMed ID: 7977175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.
    Mattson K; Holsti LR; Salmo M; Saastamoinen M; Ahlstedt S; Holsti P
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():65-70. PubMed ID: 7438124
    [No Abstract]   [Full Text] [Related]  

  • 32. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
    Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
    Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
    Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
    Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
    Havemann K; Wolf M; Holle R; Gropp C; Drings P; Manke HG; Hans K; Schroeder M; Heim M; Victor N
    Cancer; 1987 Mar; 59(6):1072-82. PubMed ID: 3028596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in chemotherapy of non-small cell lung cancer.
    Sculier JP; Klastersky J
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1329-33. PubMed ID: 6209142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible enhancement of vincristine neuropathy by VP-16.
    Thant M; Hawley RJ; Smith MT; Cohen MH; Minna JD; Bunn PA; Ihde DC; West W; Matthews MJ
    Cancer; 1982 Mar; 49(5):859-64. PubMed ID: 6277454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P; Becker H; Bülzebruck H; Djawid N; Ruchalla E; Stiefel P; Tessen HW
    Onkologie; 1988; 11 Suppl 2():47-56. PubMed ID: 2851761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
    Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.